Neurosciences & Brain Imaging Open Access
-
Journal h-index: 1
- Average acceptance to publication time (5-7 days)
-
Average article processing time (30-45 days)
Less than 5 volumes 30 days
8 - 9 volumes 40 days
10 and more volumes 45 days
Gerald H Lushington and Anthony C Barnes
For decades, a great deal of public attention has followed the search for cures for cancer, heart disease and viral infections, but the single most expensive, and seemingly intractable, medical challenge in the industrialized world is Alzheimer’s disease [1]. The history of Alzheimer’s clinical trials has been notoriously disappointing [2], but are we truly doomed to continue repeating this futility? In fact, there are grounds for hope. In recent years, in a focal areas distinct from the clinical failures, we have seen fascinating progress on several potentially convergent fronts of that may afford promising new therapeutic opportunities.
